Compare RIGL to:
Real-Time: 7.75 0.18 (2.38%) 12:47pm ET
| Last Trade: | 7.73 |
|---|---|
| Trade Time: | 12:32pm ET |
| Change: | |
| Prev Close: | 7.57 |
| Open: | 7.69 |
| Bid: | 7.72 x 700 |
| Ask: | 7.73 x 200 |
| 1y Target Est: | 15.70 |
| Day's Range: | 7.61 - 7.74 |
|---|---|
| 52wk Range: | 4.19 - 14.75 |
| Volume: | 142,561 |
| Avg Vol (3m): | 825,217 |
| Market Cap: | 400.58M |
| P/E (ttm): | N/A |
| EPS (ttm): | -3.24 |
| Div & Yield: | N/A (N/A) |
| Tue 7:30am | Eleven Rigel Product Candidate Presentations at 2009 ASH MeetingPR Newswire |
| Mon, Nov 23 | Rigel shares rise on RBC analyst upgradeAP |
| Mon, Nov 23 | Rigel Pharms upgraded by RBC Capital MktsBriefing.com |
| Tue, Nov 10 | Piper Jaffray Award Winning Analyst Says Health Care Reform Equity Valuation Fears Have Passed: Stock Picks For Q4 2009Wall Street Transcript |
| Tue, Nov 10 | Bristol Licenses Arthritis Drug: BioBuzzat TheStreet.com |
| Fri, Nov 6 | Biosimilars, Biologics, Biotech And Specialty Pharmaceuticals: Piper Jaffray Picks The Stocks And Sectors With Highest Potential Returns For InvestorsWall Street Transcript |
| Fri, Nov 6 | RIGEL PHARMACEUTICALS INC FinancialsEDGAR Online Financials |
| Wed, Nov 4 | New Star Analyst Rankings for Rigel Pharmaceuticals, Inc.StarMine |
| Tue, Nov 3 | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online |
| Tue, Nov 3 | Rigel reports $26.7M loss in Q3at bizjournals.com |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.